Cisen Pharmaceutical Co., Ltd. (SHA:603367)
China · Delayed Price · Currency is CNY 14.32
-0.28 (-1.92%)
Sep 10, 2026, 11:29 AM CST
Cisen Pharmaceutical Revenue
Cisen Pharmaceutical had revenue of 842.81M CNY in the quarter ending June 30, 2026, with 2.84% growth. This brings the company's revenue in the last twelve months to 3.40B, down -6.92% year-over-year. In the year 2025, Cisen Pharmaceutical had annual revenue of 3.44B, down -13.48%.
Revenue (ttm)
3.40B
Revenue Growth
-6.92%
P/S Ratio
1.95
Revenue / Employee
1.09M
Employees
3,114
Market Cap
6.61B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.44B | -536.86M | -13.48% |
| Dec 31, 2024 | 3.98B | -480.78M | -10.77% |
| Dec 31, 2023 | 4.46B | 396.26M | 9.75% |
| Dec 31, 2022 | 4.07B | 283.50M | 7.49% |
| Dec 31, 2021 | 3.78B | 108.43M | 2.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Northeast Pharmaceutical Group | 6.56B |
| KPC Pharmaceuticals,Inc. | 4.87B |
| Guizhou Bailing Group Pharmaceutical | 2.56B |
| Sunflower Pharmaceutical Group | 2.51B |
| Jinghua Pharmaceutical Group | 1.48B |
| Hunan Warrant Pharmaceutical Co.,Ltd | 1.45B |
| Hunan Er-Kang Pharmaceutical | 1.05B |
| Hainan Haiyao | 702.17M |